menu ☰
menu ˟

[Comment] CABG the clear choice for patients with diabetes and multivessel disease

22 Feb 2018

Whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) is the preferred revascularisation method in patients with multivessel coronary artery disease, particularly in those with diabetes, has been highly debated in the cardiovascular community for more than 20 years.1–4 CABG has been consistently superior to PCI for the endpoint of repeat revascularisation. Each advancement in PCI5,6—from balloon angioplasty to bare-metal stents and drug-eluting stents—has re-challenged CABG's primacy for multivessel disease.

Click here to view the full article which appeared in The Lancet